Timothy Devling

Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53

Aditya Arya, Asem Elfert, Timothy Devling et al. · British Journal of Cancer · 2010 · 72 citations · Full text

MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination

Maria Maguire, Paul C. Nield, Timothy Devling et al. · Cancer Research · 2008 · 50 citations · Full text

MDM2 interacts with NME2 (non-metastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motility

Radosław Polański, Maria Maguire, Paul C. Nield et al. · Carcinogenesis · 2011 · 27 citations · Full text

Loss of MTBP expression is associated with reduced survival in a biomarker‐defined subset of patients with squamous cell carcinoma of the head and neck

Nikolina Vlatković, Asem Elfert, Timothy Devling et al. · Cancer · 2011 · 24 citations · Full text

MDM2 promotes cell motility and invasiveness through a RING‐finger independent mechanism

Radosław Polański, Hazel E. Warburton, Arpita Ray‐Sinha et al. · FEBS Letters · 2010 · 22 citations · Full text